原发性肝癌患者血清CXCL13和IL-31检测的临床意义探讨

doi:10.3969/j.issn.1672-5069.2017.06.041

Abstract

Dong Zhichao. Serum chemokine CXCL13 and IL-31 in diagnosis of patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 779-780.

[1] 黎靖,陈红,雷正明,等. B7-H1在PLC中的表达及其对PLC细胞增殖和凋亡的影响. 中国老年学杂志,2016,36（8）:1832-1833.
[2] 周红梅.原发性肝癌早期鉴定标志物研究进展.现代诊断与治疗,2013,24（4）:796-797.
[3] 戴亚新,张时良,裴豪,等. 原发性肝癌和肝病患者血清甲胎蛋白异质体的检测及临床意义. 中国实验诊断学,2013,17（2）:296-298.
[4] 张如峰,杨桂文,安利国,等. 趋化因子及其受体在炎症中作用的研究进展. 国际免疫学杂志,2012,35（3）:191-196.
[5] 黄海良,丁伟伟,张胜权,等. IL–31对人支气管上皮16 HBE细胞VEGF、EGF及EGFR表达的影响及作用机制.基础医学与临床,2015,36（10）:1346-1350.
[6] 刘梅,刘吉兵,王黎明,等. PLC介入治疗中血清miR-122表达及其临床意义探讨. 中华肿瘤防治杂志,2013,20（7）:515-517.
[7] 苏惠婷,李冰,曹炬,等. CXCL13、IL-31在原发性PLC患者血清中的表达及临床意义. 中国免疫学杂志,2016,32（11）:1682-1688.
[8] 李佳红,付娜,牛学敏,等. 573例原发性肝癌病因及临床特点分析. 实用肝脏病杂志,2015,18（4）:399-402.
[9] 李慧,路潜,杨萍,等. 原发性肝癌患者的症状体验及症状群的研究进展. 中国实用护理杂志,2015,31（14）:1090-1092.
[10] 罗玉妍,何正飞,戴小军. 肿瘤微环境在肿瘤淋巴管生成中的作用. 中国肿瘤临床,2013,54（21）:1337-1340.
[11] 程海波,沈卫星,吴勉华,等. 基于肿瘤微环境的癌毒病机理论研究. 南京中医药大学学报,2014,30（2）:105-107.
[12] Litsiou E,Semitekolou M,Galani IE,et al.CXCL13 production in B cells via toll-like receptor/lymphotoxin receptor signaling is involved in lymphoid neogenesis in chronic obstructive pulmonary disease. Am J Respi Crit Care Med,2013,187（11）:1194-1202.
[13] 张岩,王铁栓,赵松,等. 趋化因子CXCL13在胸腺瘤合并重症肌无力发病中的作用. 中国老年学杂志,2012,32（12）:2484-2486.
[14] 李莹,高伟,李伟艳,等. 趋化因子CXCL13及其受体CXCR5在肿瘤中的研究进展.国际耳鼻咽喉头颈外科杂志,2016,40（3）:154-158.
[15] Kasraie S,Niebuhr M,Werfel T,et al. Interleukin （IL）-31 activates signal transducer and activator of transcription （STAT）-1,STAT-5 and extracellular signal-regulated kinase 1/2 and down-regulates IL-12p40 production in activated human macrophages.Allergy,2013,68（6）:739-747.

Serum chemokine CXCL13 and IL-31 in diagnosis of patients with primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	National Workshop on Fatty Liver, Alcoholic Liver Disease, Chinese Society of Hepatology; National Workshop on Liver, Metabolism, Chinese Society of Endocrinology, Chinese Medical Association. Committee of Hepatology, Chinese Research Hospital Association; Fatty Liver Expert Committee, Chinese Medical Doctor Association [J]. Journal of Practical Hepatology, 2019, 22(6): 787-792.
[2]	. Consensus on the diagnosis and therapy of hepatic fibrosis [J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
[3]	Cao Ce, Yu Yixing, Wang Beibei, et al.. Clinical diagnostic efficacy of enhanced magnetic resonance imaging combined with serum AFP and PIVKA-Ⅱ in the diagnosis of patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 896-899.
[4]	Zeng Yanni, Zhang Can, Bi Junying, et al.. Value of long-time delayed enhancement scan of MRI in the diagnosis of solitary necrotic nodule of liver [J]. Journal of Practical Hepatology, 2019, 22(6): 900-903.
[5]	Xing Hao, Han Jun, Yang Tian.. Diagnostic value of serum protein induced by vitamin K absence or antagonist II for hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2019, 22(6): 934-937.
[6]	Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943.
[7]	Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655.
[8]	Huang Hanjun, Lu Fengrong, Zhang Can. Clinical value of MRI scanning based on exchange hemodynamics model in evaluating liver cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 696-699.
[9]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[10]	Hong Jia, Wu Xiaoning, You Hong. Standardized diagnosis of cholestatic liver diseases [J]. Journal of Practical Hepatology, 2019, 22(5): 758-760.
[11]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[12]	Cheng Hua, Ju Hui, Song Deshun et al. Value of serum angiopoietin-like protein 2 and Golgi protein 73 levels in the diagnosis of hepatic fibrosis in patient with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 494-497.
[13]	Yu Yingfang, Wen Shengbao. Assessment of liver fibrosis with diffusion-weighted magnetic resonance imaging using single, double and stretch index model in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 502-505.
[14]	Zhang Yafei, Ye Jun, Xie Qinxiu, et al. Difference in predicting efficacy of significant liver fibrosis by noninvasive liver fibrosis index in different hospitals [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 510-513.
[15]	Xie Xiao, Liu Ting, Dong Zhixia, et al. Value of controlled attenuation parameter in diagnosis of individuals with liver steatosis by using Fibrotouch [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 526-529.